Learn More
Medchemexpress LLC RIPK1-IN-4 | 1481641-08-0 | 98.9% | 401.46 | C23H23N5O2 | 10 MG

Supplier: Medchemexpress LLC HY1890110MG
A potent, selective type II kinase inhibitor of receptor-interacting protein 1 (RIP1) that binds the DLG-out inactive conformation. It exhibits low-nanomolar biochemical potency (RIP1 IC50 16 nM; ADP-Glo IC50 10 nM) and shows cellular activity against RIP1-mediated necroptosis, making it suitable as a research tool for studies of RIP1 signaling and necroptosis.
- Potent biochemical inhibition of RIP1 (IC50 16 nM).
- Low-nanomolar ADP-Glo kinase activity (IC50 10 nM).
- Cellular efficacy in necroptosis models (L929, U-937).
- High purity and white to off-white solid appearance.
- High DMSO solubility (250 mg/mL) with ultrasonic assistance.
- Stable when stored per recommended conditions (powder and solvent).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.